Drug-makers could one day make products faster because of a $2.5 million National Science Foundation (NSF)-funded project now underway at the University of Maryland, Baltimore (UMB) and three other sites.
The cyber-infrastructure project goes to the heart of a current dilemma facing scientists trying to conduct efficient drug discovery and development from the massive data available on the human genome, says Alexander MacKerell, Grollman-Glick Professor of Pharmaceutical Sciences at the University of Maryland School of Pharmacy.
Scientists who look for new therapeutic drug opportunities from human gene and protein data have, in turn, created a “huge number of computational tools based on the mathematical models and parameters to biological molecules,” says MacKerell, who is director of the Computer-Aided Drug Design Center at the School of Pharmacy and principal investigator for the project. But, he says, such software tools are not one-size-fits-all. They are designed for different categories of molecules.
“Right now it is very tedious and time consuming to set up these mathematical models and parameters for the new molecules. Our cyber infrastructure will make this much faster. We are going to put the parameter engine in place to do the work for the scientist.”
Also funded for the cyber-infrastructure project are the Universities of Kentucky, Florida, and Illinois. Across the four universities, the project will also have applications in facilitating the design of electronics and the study of a wide range of material science and biological systems at the most basic level, in addition to drug design applications.
The project is aimed toward putting the parameter engine online. Researchers will go to the Internet, enter their drug molecule, and get the best model and the correct parameters for making their investigation more efficient. The proposed engine will provide an open architecture for obtaining and testing parameters under various conditions.
Ordinarily, once a drug company identifies a new drug candidate for the treatment of a particular medical problem, the next step is optimizing the drug candidate to improve its therapeutic potential. This is a huge task that involves testing hundreds of molecules, a task that can be facilitated using computational tools, says MacKerell. “We are trying to allow for computational tools to be rapidly applied to large numbers of molecules. We want to automate this process. To do so will allow computational scientists to work with biologists, thereby decreasing the time and cost required to develop new drug candidates.”
Also, the project will include annual workshops for education and outreach.
The basis for the Computer-Aided Drug Design Center is to ease the discovery of novel therapeutic agents that combines rational drug design methods with chemistry and structural biology. The computer-aided drug design approach allows researchers to use information available in 3-D structures of biological target molecules, which may be associated with human diseases, to identify chemicals that have a great potential for binding to those target molecules. Chemical compounds developed by such steps can often be developed into research tools and/or therapeutic agents. The NSF cyber-infrastructure project will help make this potential a reality.
Robert Latour, PhD, the McQueen-Quattlebaum Professor of Bioengineering at Clemson University, wrote a letter to the NSF supporting the project “because this is very important for a much broader spectrum of applications. It has enormous potential down the road to design things at the atomic level,” he said. Latour uses the same computational chemistry technology to simulate the interactions between biological molecules, such as proteins, and synthetic materials at the atomic level, aimed toward developing more accurate devices to detect biowarfare agents, more biocompatible implants for the human body, and other bionanotechnology applications.
Steve Berberich | Newswise Science News
Further reports about: > CHEMISTRY > Computational > Computer-Aided Drug Design Center > Cyber Chemistry > Design > Design Thinking > Drug Delivery > Drug-Making > Scientist > atomic level > biocompatible implants > biological molecules > biological system > bionanotechnology applications > computational chemistry technology > computational tools > cyber-infrastructure project > human genome > material science > therapeutic
Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel
Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)
The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.
Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...
A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.
The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
25.05.2018 | Event News
02.05.2018 | Event News
13.04.2018 | Event News
25.05.2018 | Event News
25.05.2018 | Machine Engineering
25.05.2018 | Life Sciences